Company intelligence / Profile preview
Artepharm
Fengshun (Industrial Park of Fengshun Economic Development Zone), Guangdong, Chinaartepharm.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Artequick® (artemisinin + piperaquine) is a WHO-recommended artemisinin-based combination therapy (ACT) for uncomplicated and severe falciparum malaria, with rapid fever and parasite clearance (16-30 hours and 36-60 hours, respectively) and low side effects; marketed in multiple countries including Nigeria, Tanzania, and Kenya
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Guangzhou University of Chinese Medicine
Beyond the preview
Go deeper on Artepharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artepharm.